InMed Pharmaceuticals Inc. Annual Return On Assets in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2023.
  • InMed Pharmaceuticals Inc. Return On Assets for the quarter ending December 31, 2023 was -46.2 %, a 59.3% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Return On Assets for 2023 was -52.7 %, a 54% increase from 2022.
  • InMed Pharmaceuticals Inc. annual Return On Assets for 2022 was -114 %, a 13.5% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -52.7 +61.8 +54% Jul 1, 2022 Jun 30, 2023
2022 -114 -13.7 -13.5% Jul 1, 2021 Jun 30, 2022
2021 -101 Jul 1, 2020 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.